EA200200572A1 - Применение производых 9-замещенного гипоксантина для стимуляции регенерации нервной ткани - Google Patents

Применение производых 9-замещенного гипоксантина для стимуляции регенерации нервной ткани

Info

Publication number
EA200200572A1
EA200200572A1 EA200200572A EA200200572A EA200200572A1 EA 200200572 A1 EA200200572 A1 EA 200200572A1 EA 200200572 A EA200200572 A EA 200200572A EA 200200572 A EA200200572 A EA 200200572A EA 200200572 A1 EA200200572 A1 EA 200200572A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted
hypoxantine
derivatives
application
tissue regeneration
Prior art date
Application number
EA200200572A
Other languages
English (en)
Inventor
Элвин Гласки
Original Assignee
Неотерапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неотерапьютикс, Инк. filed Critical Неотерапьютикс, Инк.
Publication of EA200200572A1 publication Critical patent/EA200200572A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Psychology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Данное изобретение включает способ стимуляции регенерации или выживания двигательного нейрона или сенсорного нейрона млекопитающих, включающий в себя введение млекопитающему эффективного количества соединения, которое является производным 9-замещенного гипоксантина, связанным через линкер с фрагментом - п-аминобензойной кислотой, или соли, или пролекарственного сложного эфира такого соединения. Предпочтительно, соединение представляет собой N-4-карбоксифенил-3-(6-оксогидропурин-9-ил)пропанамид. Изобретение также включает в себя фармацевтические композиции для стимуляции регенерации двигательного нейрона млекопитающих, содержащие производное 9-замещенного гипоксантина и фармацевтически подходящий носитель.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200572A 1999-11-16 2000-10-27 Применение производых 9-замещенного гипоксантина для стимуляции регенерации нервной ткани EA200200572A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/442,151 US6288069B1 (en) 1999-11-16 1999-11-16 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
PCT/US2000/041645 WO2001036419A1 (en) 1999-11-16 2000-10-27 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue

Publications (1)

Publication Number Publication Date
EA200200572A1 true EA200200572A1 (ru) 2003-02-27

Family

ID=23755734

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200572A EA200200572A1 (ru) 1999-11-16 2000-10-27 Применение производых 9-замещенного гипоксантина для стимуляции регенерации нервной ткани

Country Status (12)

Country Link
US (1) US6288069B1 (ru)
EP (1) EP1230242A1 (ru)
JP (1) JP2003517469A (ru)
KR (1) KR20020050283A (ru)
AU (1) AU3637901A (ru)
BR (1) BR0015574A (ru)
CA (1) CA2387809A1 (ru)
EA (1) EA200200572A1 (ru)
IL (1) IL149561A0 (ru)
MX (1) MXPA02004935A (ru)
NO (1) NO20022325L (ru)
WO (1) WO2001036419A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020091133A1 (en) * 2000-12-12 2002-07-11 Eve M. Taylor Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
US7132103B2 (en) * 2003-08-01 2006-11-07 Enhan Technology Holdings International Co., Ltd. Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury
US20080039247A1 (en) * 2006-08-02 2008-02-14 Sandra L. Uhler Footbag And A System Relating Thereto
KR102156871B1 (ko) 2020-01-13 2020-09-24 주식회사 제이에스티 비산 저감이 가능한 집진장치를 이용한 하이브리드 폴리우레아 복합방수공법

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321369A (en) 1965-05-26 1967-05-23 Abbott Lab Method of enhancing learning rate and retention level in warm blooded animals
US3438486A (en) 1966-08-17 1969-04-15 David Pinkas Pick array
BE759011A (fr) 1969-11-17 1971-05-17 Wellcome Found Aminopurines
DE2554453A1 (de) 1974-12-18 1976-06-24 Experimentales Et Cliniques De Medikament zur glykaemieregulierung
US4221909A (en) 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4340726A (en) 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4643992A (en) 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5093318A (en) 1983-11-01 1992-03-03 Scripps Clinic And Research Foundation Immunostimulating guanosine derivatives and their pharmaceutical compositions
US4952693A (en) 1984-10-12 1990-08-28 Warner-Lambert Company Oxazolo-pyrimidine derivatives
US5495010A (en) 1987-04-17 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services Acid stable purine dideoxynucleosides
DE3855442T2 (de) 1988-04-19 1997-03-06 Inst Nat Sante Rech Med Verfahren zur Gewinnung von Schutzantigenen gegen Bordetella-Infektionen und toxische Prozesse
IT1227389B (it) 1988-07-07 1991-04-08 Mini Ricerca Scient Tecnolog Dispersioni acquose di polimeri uretano-acrilici e loro impiego come vernici.
US5256677A (en) 1989-05-23 1993-10-26 Abbott Laboratories Retroviral protease inhibiting compounds
US5187162A (en) 1989-09-15 1993-02-16 Gensia Pharmaceuticals Methods of treating neurodegenerative conditions
US5026687A (en) 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
US5091432A (en) 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5237051A (en) 1990-12-06 1993-08-17 Vanderbilt University Purified enterotoxin receptor protein
US5447939A (en) 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US5801184A (en) 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US5795756A (en) 1995-12-11 1998-08-18 Johnson; Roger A. Method and compounds for the inhibition of adenylyl cyclase
US5948771A (en) 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
US5801159A (en) 1996-02-23 1998-09-01 Galileo Laboratories, Inc. Method and composition for inhibiting cellular irreversible changes due to stress
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
AU3785799A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Method for treating migraine in mammals
AU3879899A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel dopamine-like 9-substituted hypoxanthine and methods of use

Also Published As

Publication number Publication date
NO20022325D0 (no) 2002-05-15
WO2001036419A9 (en) 2002-08-08
JP2003517469A (ja) 2003-05-27
CA2387809A1 (en) 2001-05-25
US6288069B1 (en) 2001-09-11
EP1230242A1 (en) 2002-08-14
AU3637901A (en) 2001-05-30
MXPA02004935A (es) 2005-09-08
WO2001036419A1 (en) 2001-05-25
IL149561A0 (en) 2002-11-10
NO20022325L (no) 2002-05-15
BR0015574A (pt) 2005-04-12
KR20020050283A (ko) 2002-06-26

Similar Documents

Publication Publication Date Title
DK170438B1 (da) 3-Indolpyrodruesyrederivater, lægemidler indeholdende sådanne, samt anvendelse af sådanne derivater til fremstilling af lægemidler
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
CY1109558T1 (el) Παραγωγα βενζο[d]αζεπινης για την θεραπεια νευρολογικων διαταραχων
BR9810841A (pt) Inibidores de metaloprotease alicìclicos
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
EA200100750A1 (ru) Способ лечения сексуальных нарушений
WO2001078711A3 (en) Pde-v inhibitors for treatment of parkinson's disease
CO4920242A1 (es) Compuestos inhibidores de metalopreoteasas 1,4-heterocicli- cos, composiciones farmaceuticas que los contienen y metodos para su utilizacion
DE60130023D1 (de) Behandlung der nebenwirkungen von statinen
EA200500814A1 (ru) Производные пирролопиримидина
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
EP1862458A3 (en) Therapeutic agents useful for treating pain
EA200100203A1 (ru) Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов
ES2156156T3 (es) Compuesto terapeutico - conjugados de acidos grasos.
EA200801711A1 (ru) Пролекарства возбуждающих аминокислот
RU95113148A (ru) Производное 2-(2-амино-1,6-дигидро-6-оксопурин-9-ил)-метокси-1,3-пропандиола
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
EA199901075A1 (ru) Лечение резистентности к инсулину средствами, стимулирующими секрецию гормона роста
EA200200562A1 (ru) Антагонисты аденозиновых рецепторов и способы их получения и использования
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
EP0304223A2 (en) Beta-carbolines as cholecy-stokinin and gastrin antagonist
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
CO5390085A1 (es) Metodo para tratar enfermedades o condiciones desmielinizantes
EA200200572A1 (ru) Применение производых 9-замещенного гипоксантина для стимуляции регенерации нервной ткани